Loading clinical trials...
Loading clinical trials...
Balance impairment is a common and very disabling disturbance in people with Multiple Sclerosis. The efficacy of pharmacotherapy in treating balance impairment in MS is poorly documented in literature...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universita di Verona
NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy
NCT05758831 · Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
NCT06586177 · Relapsing-remitting Multiple Sclerosis
NCT05906992 · Relapsing-remitting Multiple Sclerosis
NCT05123703 · Relapsing-Remitting Multiple Sclerosis
S.S.O. di Riabilitazione dell'Ospedale Policlinico
Verona, Verona
Section of Clinical Neurology, Department Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy
Verona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions